US Patent Issued to MESHABERASE, The United States of America as Represented by the Secretary Department of Health & Human Services on June 30 for "Use of cysteamine and derivatives thereof to suppress tumor metastases" (Maryland Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,547, issued on June 30, was assigned to MESHABERASE LLC (Potomac, Md.) and The United States of America as Represented by the Secretary Department of Health & Human Services (Bethesda, Md.).

"Use of cysteamine and derivatives thereof to suppress tumor metastases" was invented by Benjamin Rubin (Potomac, Md.), Mark Gilbert (Bethesda, Md.) and Jinkyu Jung (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method f...